Full history for every metric is available with a Kvantra account

Stock profile

Inari Medical, Inc. (NARI)

Country: United States of AmericaSector: HealthcareIndustry: Medical - DevicesExchange: NASDAQ

Delisted · last close 19 Feb 2025

Current price
79.97 USD0.00%
Last close 19 Feb 2025
Benchmarks

Key financial summary

Financials in USD
201820192020202120222023TTM
Total revenue$m751140277383494574
Operating profit$m-14-48
Net profit$m-10-21410-29-2-79
EPS reported$-0.03-1.35
Operating cashflow per share$0.630.63
Capex per share$0.110.11
FCF per share$0.520.52
Free cash flow$m302
Net debt$m-115-112
Book value equity$m465435
Book value per share$8.197.45
Number of sharesm56.7758.37
DPS (TTM paid)$0.000.00

Financial summary

Financials in USD
201820192020202120222023TTM
Value
P/E TTMx--
P/B LTMx7.9310.77
P/S LTMx7.478.15
P/FCF LTMx123.982,962.26
EV/EBITDA LTMx242.25-126.44
EV/Sales LTMx7.457.96
Earnings Yield LTM%-0.04%-0.04%
FCF Yield%0.81%0.03%
Quality
ROE%-0.35%-0.37%
ROIC%0.90%0.90%
Operating margin%-2.84%-2.84%
Gross margin%88.03%88.03%
FCF/Sales%6.02%6.02%
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%+28.73%+22.41%
Net Income Growth YoY%--
FCF Growth%--94.62%
Operating Profit Growth%--
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx0.930.05
Net Debt/EBITDAx-0.43-0.43
EBIT/Net interestx-71.59-71.59
Net debt/market cap%-3.13%-2.38%
Net debt/Equityx-0.25-0.26
Gross debt/equityx0.070.08

Company overview

Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.

WebsiteN/A
IndustryMedical - Devices
Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 19 Feb 2025

Inari Medical, Inc. (NARI)

NARI · NASDAQ · Healthcare
79.97 USD0.00%
Benchmarks
Financialsin USD
20222023TTM
About

Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.

IndustryMedical - Devices
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free